Ladybug's Acquisition of E-Commerce Platform Set to Boost Annual Revenue by $2.5 Million, Aligning with Revenue Target for 2024
03 avr. 2024 08h05 HE
|
LadyBug Resource Group, Inc.
Ladybug's Acquisition of E-Commerce Platform Set to Boost Annual Revenue by $2.5 Million, Aligning with Revenue Target for 2024.
Ladybug Resource Group Continues to Strive Toward $25 Million 2024 Revenue Goal.
27 mars 2024 08h00 HE
|
LadyBug Resource Group, Inc.
Ladybug Resource Group Continues to Strive Toward $25 Million 2024 Revenue Goal.
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
20 févr. 2024 08h38 HE
|
Fractyl Health, Inc.
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
US-Based Yes You Can! Appoints New Executive Team to Lead Global Market Expansion
04 nov. 2021 16h00 HE
|
Yes You Can!
MIAMI, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Alejandro Chaban, CEO & Founder of health and wellness social networking company Yes You Can! (YYC!), plans to bring awareness of his easy-to-follow...
Obalon Announces Fourth Quarter and Full Year 2020 Financial Results
12 mars 2021 19h12 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Third Quarter 2020 Financial Results
06 nov. 2020 16h45 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Second Quarter 2020 Financial Results
30 juil. 2020 06h38 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces First Quarter 2020 Financial Results and Business Update
19 juin 2020 06h15 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
11 mai 2020 08h30 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
08 mai 2020 08h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...